Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)|August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacementMi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve ReplacementYeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
American Heart Journal|December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trialMijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
Pageof 3